is trulicity tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide Tirzepatide Matches Dulaglutide in Large

In 2022, 1 in 8 individuals globally were living with obesity

Pair them with the Compound Code to lock results in for good

Standard dosing suggests one capsule twice daily on an empty stomach

Referral to specialists should be considered when patients have persistent A1C elevations despite combination therapy, complex obesity requiring specialized care, or when evaluating bariatric surgery options (typically for BMI 40 kg/m or 35 kg/m with comorbidities)

The formulation pairs a growth hormonereleasing hormone (GHRH) analogue with a selective growth hormone secretagogue analogue, allowing researchers to examine coordinated signalling through distinct receptor mechanisms